BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31771043)

  • 1. Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma.
    Saman S; Stagno MJ; Warmann SW; Malek NP; Plentz RR; Schmid E
    Cancer Biomark; 2020; 27(1):129-137. PubMed ID: 31771043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.
    Grimm M; Kraut W; Hoefert S; Krimmel M; Biegner T; Teriete P; Cetindis M; Polligkeit J; Kluba S; Munz A; Reinert S
    Clin Oral Investig; 2016 Mar; 20(2):329-38. PubMed ID: 26153867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells.
    Grimm M; Schmitt S; Teriete P; Biegner T; Stenzl A; Hennenlotter J; Muhs HJ; Munz A; Nadtotschi T; König K; Sänger J; Feyen O; Hofmann H; Reinert S; Coy JF
    BMC Cancer; 2013 Dec; 13():569. PubMed ID: 24304513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope Detection in Monocytes (EDIM) As a New Method of Liquid Biopsy in Pediatric Rhabdomyosarcoma.
    Urla C; Stagno MJ; Schmidt A; Handgretinger R; Fuchs J; Warmann SW; Schmid E
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer.
    Todenhöfer T; Hennenlotter J; Keller G; Neumann T; Stenzl A; Bedke J
    Prostate; 2017 Sep; 77(12):1251-1258. PubMed ID: 28726251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic use of epitope detection in monocytes blood test for early detection of colon cancer metastasis.
    Jansen N; Coy JF
    Future Oncol; 2013 Apr; 9(4):605-9. PubMed ID: 23560382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer.
    Coy JF
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28425973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma-a pilot study.
    Stagno MJ; Schmidt A; Bochem J; Urla C; Handgretinger R; Cabanillas Stanchi KM; Saup R; Queudeville M; Fuchs J; Warmann SW; Schmid E
    Br J Cancer; 2022 Oct; 127(7):1324-1331. PubMed ID: 35864157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of circulating CD14+/CD16+ monocyte-derived macrophages (MDMs) in the peripheral blood of patients with oral squamous cell carcinoma.
    Grimm M; Feyen O; Coy JF; Hofmann H; Teriete P; Reinert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):301-6. PubMed ID: 26747736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies.
    Feyen O; Coy JF; Prasad V; Schierl R; Saenger J; Baum RP
    Future Oncol; 2012 Oct; 8(10):1349-59. PubMed ID: 23130932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apo10 and TKTL1 in blood macrophages as biomarkers for differentiating lung cancer from benign lung lesions: a comparative study with conventional biomarkers.
    Xie C; Wang S; Guo C; Liu Y; Zeng M
    Cell Oncol (Dordr); 2023 Dec; 46(6):1725-1729. PubMed ID: 37378867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
    Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
    Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
    Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
    Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.